SPONSOR
Hiroshima University
Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Stroke
Hiroshima University is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Stroke.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hiroshima University
How many clinical trials has Hiroshima University sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Hiroshima University, of which 1 are actively recruiting participants. These trials cover conditions including Stroke. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hiroshima University research focus on?
Hiroshima University clinical trials span Stroke. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Hiroshima University clinical trial?
To participate in a Hiroshima University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hiroshima University trials with current recruitment status updated daily.
Clinical Trials by Hiroshima University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology